Cholestyramine drug interactions: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Redirected page to Cholestyramine)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Cholestyramine]]
{{Cholestyramine}}
{{CMG}}; {{AE}} {{SS}}
 
==Drug Interactions==
Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as [[phenylbutazone]], [[warfarin]],[[ thiazide diuretics]] ([[acidic]]), or [[propranolol]] (basic), as well as [[tetracycline]], [[penicillin G]], [[phenobarbital]], thyroid and thyroxine preparations, [[estrogen]]s and [[progestin]]s, and [[digitalis]]. Interference with the absorption of oral phosphate supplements has been observed with another positively-charged bile acid sequestrant. Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation. The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as [[digitalis]] has been titrated to a maintenance level while the patient was taking cholestyramine resin.
 
Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat-soluble vitamins such as A, D, E and K. When cholestyramine resin is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of fat-soluble vitamins should be considered.
 
'''SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST ONE HOUR BEFORE OR 4 TO 6 HOURS AFTER PREVALITE® (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.'''<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PREVALITE (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [UPSHER-SMITH LABORATORIES INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd434ef8-8af3-434c-a0a0-9a0b18459ba0 | publisher =  | date =  | accessdate = 10 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
{{Lipid modifying agents}}
 
[[Category:Hepatology]]
[[Category:Bile acid sequestrants]]
[[Category:Cardiovasuclar Drugs]]
[[Category:Drugs]]

Latest revision as of 13:52, 21 July 2014

Redirect to: